(Q28181141)

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Acute graft-vs-host disease: pathobiology and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Cloning of a new cytokine that induces IFN-gamma production by T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

A newly defined interleukin-1?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

The role of IL-18 in innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Interleukin-18 regulates both Th1 and Th2 responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Interleukin 18: tipping the balance towards a T helper cell 1 response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

IL-18 prevents the development of chronic graft-versus-host disease in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Interleukin-18 binding protein in acute graft versus host disease and engraftment following allogeneic peripheral blood stem cell transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Kinetics of interferon-gamma secretion and its regulatory factors in the early phase of acute graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Interferon gamma is required for activation-induced death of T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Neuroblastoma cells expressing mature IL-18, but not proIL-18, induce a strong and immediate antitumor immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Interferon-gamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Dose and timing of interleukin (IL)-12 and timing and type of total-body irradiation: effects on graft-vs.-host disease inhibition and toxicity of exogenous IL-12 in murine bone marrow transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Role of interleukin-12 in acute graft-versus-host disease(1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

IL-18-independent cytotoxic T lymphocyte activation and IFN-gamma production during experimental acute graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Interleukin-18 stimulates hematopoietic cytokine and growth factor formation and augments circulating granulocytes in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Further checkpoints in Th1 development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Tolerance and autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

T cell death and transplantation tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

Differential roles of IL-18 in allergic airway disease: induction of eotaxin by resident cell populations exacerbates eosinophil accumulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2803%2900028-3

10.1016/S0022-2143(03)00028-3

7 January 2021

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

12819633

1 reference

Consolidated OpenCitations Corpus – April 2017